180 Life Sciences reports $349 million ETH holdings after strategy shift Aug 12, 2025 08:01AM
180 Life Sciences closes $156 million convertible note offering Aug 11, 2025 08:01AM
180 Life Sciences Corp (ATNF) Strength Tied to Chatter of ETH Treasury Jul 28, 2025 03:31PM
180 Life Sciences Corp (ATNF) Announces Strengthening of Legacy Intellectual Property Assets Jul 1, 2025 07:46AM
180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets Jul 1, 2025 07:30AM


Jun 20, 2025 04:18PM 180 Life Sciences Corp (ATNF) Files $500M Mixed Shelf
May 1, 2025 09:32AM 180 Life Sciences Corp (ATNF) Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
May 1, 2025 09:30AM 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
Apr 30, 2025 08:35AM 180 Life Sciences Corp (ATNF) announces stock buyback
Apr 30, 2025 08:30AM 180 Life Sciences Corp. Announces Share Repurchase
Dec 27, 2024 09:03AM 180 Life Sciences Corp (ATNF) Prices 1.2M Share Offering at $2.41/sh
Dec 27, 2024 09:00AM 180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
Dec 4, 2024 08:03AM 180 Life Sciences Corp (ATNF) Appoints Stephen Shoemaker to its Board
Dec 4, 2024 08:00AM 180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
Oct 31, 2024 08:00AM 180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
Oct 29, 2024 08:04AM 180 Life Sciences Corp (ATNF) Appoints Jay Goodman to its Board
Oct 29, 2024 08:00AM 180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
Oct 16, 2024 10:03AM 180 Life Sciences Corp (ATNF) Halted on Volatility, Off Highs, Up 480%
Oct 16, 2024 08:03AM 180 Life Sciences Corp (ATNF) Interim CEO Blair Jordan Issues Letter to Stockholders
Oct 16, 2024 08:00AM 180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
Oct 9, 2024 08:32AM 180 Life Sciences Corp (ATNF) Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
Oct 9, 2024 08:30AM 180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
Oct 3, 2024 08:30AM 180 Life Sciences Corp. - Corporate Updates
Jul 30, 2024 08:01AM 180 Life Sciences Corp (ATNF) Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
Jul 2, 2024 08:30AM 180 Life Sciences Corp (ATNF) Granted Extension to Regain Nasdaq Compliance